Is ZTS Worth Buying in 2026?

ZOETIS INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether ZOETIS INC. (ZTS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: above the 50-day MA (medium-term momentum positive). Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-0.71% over 10 days); RSI 70 — overbought, elevated pullback risk; weak 1-year return of -16.6%. Currently 28.9% off its 52-week high. Score: -4/7.

Ready to act on this? 📈 Trade on Webull

ZTS is trading below its 200-day MA ($134.19) — a key warning sign the longer-term trend is under pressure. With an RSI of 70.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -16.6% compares to +35.1% for SPY (trailed the market by 51.7%). The current 28.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $8,339 today
vs. S&P 500 (SPY) — same period trailed market by 51.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($134.19)
Above 50-day MA ($121.93)
!RSI(14) neutral zone (30–70) — currently 70.3
Positive return (-16.6%)
!Within 10% of period high (−28.9%)
Period Range $122.38
$113.29 $172.23
RSI (14) 70.3
0 · OversoldOverbought · 100

Key Metrics

Price$122.38
Period Return-16.6%
Period High$172.23
Period Low$113.29
Drawdown−28.9%
MA-50$121.93
MA-200$134.19
RSI (14)70.3
Avg Volume (30d)3.7M
vs. SPYtrailed by 51.7%
Return Rank#798 of 996

Trade ZTS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers